entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 21:10:01 - browse：5849

A heart monitoring watch, referred as Project Zero 2.0 is displayed in the Omron Healthcare booth during a press event – health tech coverage from STAT — Digital tools to better track blood pressure over time and encourage adherence to treatment plans are increasingly commonplace. David Becker/Getty Images

If you have high blood pressure, it’s increasingly likely that your doctor or your insurer will offer you a blood pressure cuff or an educational app to help you get it under control. While potentially impactful, these tools may not be reaching marginalized people who don’t regularly have access to good health care — and who may benefit the most from the tools.

A new analysis suggests that there ought to be more investment in novel hypertension programs for people experiencing health disparities.The meta-review of 28 studies of digital health interventions for people of color and low-income patients found that as a whole participants saw a statistically significant and clinically meaningful reduction in average systolic blood pressure compared to control groups. In total, the analysis included more than 8,000 participants; most of the studies followed participants for six or 12 months. The results, published Wednesday in JAMA Network Open, are consistent with studies of digital tools in the general population.

Joseph Ebinger, of the Smidt Heart Institute at Cedars-Sinai in Los Angeles, who was not involved in the study, said it provides needed evidence that “there are tools that exist to be able to help meet individuals where they are in the world, and they should be utilized more heavily.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Health tech startups drop sharply from 2021 highs

explore

WSS

Cigna to pay $172 million to settle Medicare Advantage fraud probe

FDA seeks to regulate lab

Would Medicare drug price negotiations stall in a shutdown?

Study suggests new cause of Down syndrome: cells linked to aging

Why do women spend more than men on medical expenses?

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

hotspot

entertainment

focus

Walensky prepares to leave CDC — and Congress — behind

Physician assistants need a new name. Here's what it should be

In age of alternative facts, a scholarly course on calling out crap

Arena BioWorks launches in Cambridge to speed drug discovery

Peter Hotez and the public health issue of online harassment

Biogen shutters digital health group, ends Apple study, in cost cutting move

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

State Dept. review finds Biden bears some blame for Afghanistan failures

Male doctors called my cancer incurable. A female doctor showed it wasn't

leisure time

A preacher's new calling: Diversifying neuroscience research

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Medicare Advantage overpayments discussion gets experts fired up

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

WHO recommends dropping component of many flu vaccines

At JPM 2024, hospital systems pitch financial strength to investors

knowledge

explore

hotspot

explore